questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Vecteurs génétiques
Vecteurs génétiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vecteurs génétiques : Questions médicales les plus fréquentes",
"headline": "Vecteurs génétiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vecteurs génétiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vecteurs génétiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Structures génétiques",
"url": "https://questionsmedicales.fr/mesh/D040342",
"about": {
"@type": "MedicalCondition",
"name": "Structures génétiques",
"code": {
"@type": "MedicalCode",
"code": "D040342",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels",
"alternateName": "Chromosomes, Artificial",
"url": "https://questionsmedicales.fr/mesh/D022201",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels",
"code": {
"@type": "MedicalCode",
"code": "D022201",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels de bactérie",
"alternateName": "Chromosomes, Artificial, Bacterial",
"url": "https://questionsmedicales.fr/mesh/D022202",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels de bactérie",
"code": {
"@type": "MedicalCode",
"code": "D022202",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.170"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels de mammifère",
"alternateName": "Chromosomes, Artificial, Mammalian",
"url": "https://questionsmedicales.fr/mesh/D022221",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels de mammifère",
"code": {
"@type": "MedicalCode",
"code": "D022221",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.190"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels humains",
"alternateName": "Chromosomes, Artificial, Human",
"url": "https://questionsmedicales.fr/mesh/D022222",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels humains",
"code": {
"@type": "MedicalCode",
"code": "D022222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.190.117"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels humains",
"alternateName": "Chromosomes, Artificial, Human",
"url": "https://questionsmedicales.fr/mesh/D022222",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels humains",
"code": {
"@type": "MedicalCode",
"code": "D022222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.190.117"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromosome artificiel du bactériophage P1",
"alternateName": "Chromosomes, Artificial, P1 Bacteriophage",
"url": "https://questionsmedicales.fr/mesh/D027042",
"about": {
"@type": "MedicalCondition",
"name": "Chromosome artificiel du bactériophage P1",
"code": {
"@type": "MedicalCode",
"code": "D027042",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.195"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels de levure",
"alternateName": "Chromosomes, Artificial, Yeast",
"url": "https://questionsmedicales.fr/mesh/D018244",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels de levure",
"code": {
"@type": "MedicalCode",
"code": "D018244",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.200"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vecteurs génétiques",
"alternateName": "Genetic Vectors",
"code": {
"@type": "MedicalCode",
"code": "D005822",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Joel O Odero",
"url": "https://questionsmedicales.fr/author/Joel%20O%20Odero",
"affiliation": {
"@type": "Organization",
"name": "International Centre of Insect Physiology and Ecology (icipe), P.O. Box 30772-00100, Nairobi, Kenya."
}
},
{
"@type": "Person",
"name": "John M Marshall",
"url": "https://questionsmedicales.fr/author/John%20M%20Marshall",
"affiliation": {
"@type": "Organization",
"name": "5Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, California."
}
},
{
"@type": "Person",
"name": "Mauro Toledo Marrelli",
"url": "https://questionsmedicales.fr/author/Mauro%20Toledo%20Marrelli",
"affiliation": {
"@type": "Organization",
"name": "Institute of Tropical Medicine, University of São Paulo, São Paulo 05403-000, Brazil."
}
},
{
"@type": "Person",
"name": "Elizabeth Hemming-Schroeder",
"url": "https://questionsmedicales.fr/author/Elizabeth%20Hemming-Schroeder",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecology and Evolutionary Biology and Program in Public Health, University of California, Irvine, CA, 92617, USA."
}
},
{
"@type": "Person",
"name": "Daibin Zhong",
"url": "https://questionsmedicales.fr/author/Daibin%20Zhong",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecology and Evolutionary Biology and Program in Public Health, University of California, Irvine, CA, 92617, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Balance Function after Balance Exercise Assist Robot Therapy in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Pilot Study.",
"datePublished": "2023-02-08",
"url": "https://questionsmedicales.fr/article/36793372",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2490/prm.20230003"
}
},
{
"@type": "ScholarlyArticle",
"name": "The assistance of BAZAR robot promotes improved upper limb motor coordination in workers performing an actual use-case manual material handling.",
"datePublished": "2023-01-26",
"url": "https://questionsmedicales.fr/article/36688620",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/00140139.2023.2172213"
}
},
{
"@type": "ScholarlyArticle",
"name": "Springtail-inspired Light-driven Soft Jumping Robots Based on Liquid Crystal Elastomers with Monolithic Three-leaf Panel Fold Structure.",
"datePublished": "2023-01-24",
"url": "https://questionsmedicales.fr/article/36624053",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/anie.202218227"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mending the Gap: AlloDerm as a Safe and Effective Option for Vaginal Canal Lining in Revision Robotic Assisted Gender Affirming Peritoneal Flap Vaginoplasty.",
"datePublished": "2023-01-13",
"url": "https://questionsmedicales.fr/article/36642117",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.urology.2023.01.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Influence of Preoperative Nutritional and Systemic Inflammatory Status on Perioperative Outcomes following Da Vinci Robot-Assisted Thoracic Lung Cancer Surgery.",
"datePublished": "2023-01-10",
"url": "https://questionsmedicales.fr/article/36675482",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/jcm12020554"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vecteurs génétiques",
"item": "https://questionsmedicales.fr/mesh/D005822"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vecteurs génétiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vecteurs génétiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vecteurs génétiques",
"description": "Comment identifier un vecteur génétique ?\nQuels tests pour évaluer l'efficacité d'un vecteur ?\nQuels marqueurs sont utilisés pour les vecteurs ?\nComment détecter des vecteurs viraux ?\nQuels sont les critères de sécurité des vecteurs ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Robotics&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vecteurs génétiques",
"description": "Quels symptômes d'une thérapie génique ?\nY a-t-il des effets secondaires des vecteurs ?\nComment les vecteurs affectent-ils les cellules ?\nQuels signes d'infection par vecteur viral ?\nLes vecteurs peuvent-ils causer des tumeurs ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Robotics&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vecteurs génétiques",
"description": "Comment prévenir les effets indésirables des vecteurs ?\nY a-t-il des protocoles de sécurité pour les vecteurs ?\nComment minimiser les risques d'infection ?\nLes vaccins utilisent-ils des vecteurs ?\nComment évaluer la sécurité des vecteurs ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Robotics&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vecteurs génétiques",
"description": "Comment les vecteurs sont-ils utilisés en thérapie ?\nQuels types de vecteurs sont courants ?\nComment choisir un vecteur pour un traitement ?\nQuels vecteurs pour les maladies héréditaires ?\nLes vecteurs peuvent-ils être administrés par voie orale ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Robotics&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vecteurs génétiques",
"description": "Quelles complications peuvent survenir avec les vecteurs ?\nLes vecteurs peuvent-ils causer des maladies auto-immunes ?\nComment gérer les complications des vecteurs ?\nLes vecteurs peuvent-ils provoquer des allergies ?\nQuels sont les risques de transmission de maladies ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Robotics&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vecteurs génétiques",
"description": "Quels facteurs augmentent les risques liés aux vecteurs ?\nLes patients immunodéprimés sont-ils à risque ?\nComment l'âge influence-t-il les risques ?\nLes antécédents d'allergies sont-ils un facteur ?\nQuels vecteurs sont plus risqués ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Robotics&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un vecteur génétique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs génétiques sont identifiés par leur capacité à transporter des gènes et à les exprimer."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité d'un vecteur ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de transfection et d'expression génique sont utilisés pour évaluer l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour les vecteurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs fluorescents ou de résistance aux antibiotiques sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Comment détecter des vecteurs viraux ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la PCR et le séquençage sont utilisées pour détecter des vecteurs viraux."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de sécurité des vecteurs ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs doivent être non pathogènes et ne pas induire de réponse immunitaire excessive."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une thérapie génique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des réactions immunitaires, des inflammations ou des douleurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des vecteurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées ou des réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les vecteurs affectent-ils les cellules ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs peuvent modifier l'expression génique, entraînant des changements fonctionnels."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection par vecteur viral ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fièvre, fatigue, et symptômes respiratoires selon le vecteur."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils causer des tumeurs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il existe un risque théorique que certains vecteurs induisent des tumeurs par insertion génique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets indésirables des vecteurs ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation rigoureuse et des tests précliniques peuvent aider à prévenir les effets indésirables."
}
},
{
"@type": "Question",
"name": "Y a-t-il des protocoles de sécurité pour les vecteurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des protocoles de sécurité stricts sont établis pour l'utilisation des vecteurs en recherche."
}
},
{
"@type": "Question",
"name": "Comment minimiser les risques d'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des vecteurs non pathogènes et suivre des pratiques de laboratoire sécurisées."
}
},
{
"@type": "Question",
"name": "Les vaccins utilisent-ils des vecteurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains vaccins utilisent des vecteurs pour introduire des antigènes dans l'organisme."
}
},
{
"@type": "Question",
"name": "Comment évaluer la sécurité des vecteurs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études cliniques et des évaluations de risques sont nécessaires pour évaluer la sécurité."
}
},
{
"@type": "Question",
"name": "Comment les vecteurs sont-ils utilisés en thérapie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour délivrer des gènes thérapeutiques dans des cellules cibles."
}
},
{
"@type": "Question",
"name": "Quels types de vecteurs sont courants ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs viraux, plasmidiques et lipidiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Comment choisir un vecteur pour un traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choix dépend de la cible cellulaire, de la taille du gène et de la sécurité."
}
},
{
"@type": "Question",
"name": "Quels vecteurs pour les maladies héréditaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs viraux comme les lentivirus sont souvent utilisés pour les maladies héréditaires."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils être administrés par voie orale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains vecteurs peuvent être administrés oralement, mais l'efficacité est souvent limitée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les vecteurs ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des réactions immunitaires, des infections et des tumeurs."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils causer des maladies auto-immunes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il existe un risque potentiel que certains vecteurs déclenchent des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des vecteurs ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut le suivi médical, des traitements symptomatiques et des ajustements de dosage."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils provoquer des allergies ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques peuvent survenir en réponse aux vecteurs utilisés."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de transmission de maladies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il y a un risque de transmission de maladies si des vecteurs viraux sont mal utilisés."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent les risques liés aux vecteurs ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents médicaux, l'âge et le type de vecteur utilisé peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Les patients immunodéprimés sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients immunodéprimés peuvent avoir un risque accru d'effets indésirables."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il les risques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé peut affecter la réponse immunitaire et augmenter les risques d'effets indésirables."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies sont-ils un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies peuvent augmenter le risque de réactions aux vecteurs."
}
},
{
"@type": "Question",
"name": "Quels vecteurs sont plus risqués ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs viraux, en particulier ceux dérivés de virus pathogènes, présentent plus de risques."
}
}
]
}
]
}
└─
Chromosomes artificiels
Chromosomes, Artificial
D022201
-
G05.360.337.249
└─└─
Chromosomes artificiels de bactérie
Chromosomes, Artificial, Bacterial
D022202
-
G05.360.337.249.170
└─└─
Chromosomes artificiels de mammifère
Chromosomes, Artificial, Mammalian
D022221
-
G05.360.337.249.190
└─└─
Chromosome artificiel du bactériophage P1
Chromosomes, Artificial, P1 Bacteriophage
D027042
-
G05.360.337.249.195
└─└─
Chromosomes artificiels de levure
Chromosomes, Artificial, Yeast
D018244
-
G05.360.337.249.200
└─└─└─
Chromosomes artificiels humains
Chromosomes, Artificial, Human
D022222
-
G05.360.337.249.190.117
This study compared the balance function in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT) with their balance function after subsequent training sessions with a Balance ...
In this prospective observational study, inpatients who underwent allo-HSCT from human leukocyte antigen-mismatched relatives were enrolled from December 2015 to October 2017. Patients were allowed to...
Fourteen patients providing written informed consent fulfilled the protocol: six patients in the Low group, and eight patients in the High group. In the Low group, there was a statistically significan...
BEAR sessions improve balance function in patients undergoing allo-HSCT....
This study aims at evaluating upper limb muscle coordination and activation in workers performing an actual use-case manual material handling (MMH). The study relies on the comparison of the workers' ...
Jump is an important form of motion that enables animals to escape from predators, increase their range of activities, and better adapt to the environment. Inspired by springtails, we describe a light...
To address instances when there is insufficient remnant tissue to perform revision following canal-deepening gender affirming vaginoplasty revisions as indicated by insufficient depth. Options for lin...
Retrospective analysis of 9 patients who underwent revision RPV with AlloDerm was performed. Tubularized AlloDerm grafts were used to connect remnant vaginal lining to the peritoneal flaps. Revision i...
Nine patients underwent revision RPV using AlloDerm for canal deepening. Median follow-up was 368 days (Range 186-550). Following revision, median depth and width at last follow-up were 12.1 cm and 3....
AlloDerm is an off-the-shelf option that does not require a secondary donor site. The use of AlloDerm for a pilot cohort of patients lacking sufficient autologous tissue for revision RPV alone was dem...
Background: Nutrition is an important factor in the outcome of any disease process. We evaluated the relationship of nutritional status and inflammatory status of non-small cell lung cancer (NSCLC) pa...
The purpose of this study was to compare the survival, recurrence, and complication rates in patients with pancreatic ductal adenocarcinoma (PDAC) who underwent robotic pancreaticoduodenectomy (RPD) o...
We compared the clinical outcomes of robot-assisted radical prostatectomy (RARP) and partial gland ablation (PGA) using high-intensity focused ultrasound (HIFU) in localized prostate cancer....
We analyzed 3,859 patients who had undergone RARP and PGA using HIFU. According to the propensity score for each treatment, 137 patients after PGA were matched to 3,722 patients after RARP at a 1:4 ra...
The matched cohort comprised 685 subjects (RARP, 548; PGA, 137), with a median follow-up period of 22 months. Treatment failures were identified in 13.9% and 9.1% of patients in the PGA and RARP group...
PGA using HIFU showed statistically inferior oncological outcomes compared with RARP for failure-free survival and salvage-free survival. However, functional outcomes regarding postoperative incontine...
To assess the position of the haptics of the implantable collamer lens (ICL) in myopic eyes using a high-frequency ultrasound robotic scanner....
This was a prospective, single-arm, observational study carried out at the Instituto Zaldivar SA (Mendoza, Argentina) in a sample of 52 eyes who have been submitted to successful ICL implantation prio...
In 81% of cases (42 eyes), the ICL rests on the ciliary body (CB) in both temporal and nasal sides, being slightly lower than 6% (3 eyes) those that rest on the sulcus in both sides, with significant ...
ICL for myopia footplates tend to locate outside of the sulcus in a significant percentage of patients after successful implantation. VHFDU assessment in eyes implanted with an ICL to properly study t...
Laparoscopic (LSC) Heller myotomy (HM) is considered the standard procedure for the treatment of achalasia. Robotic platforms, established over the last years, provide important advantages to surgeons...
Between August 2007 and April 2020, 43 patients undergoing minimally invasive HM for achalasia in a single high-volume Swiss visceral surgery center, were included in the present study. Intra- and pos...
A total of 11 patients undergoing RAL and 32 undergoing LSC HM were analyzed. Baseline demographics and clinical characteristics were similar. A trend (p = 0.052) towards a higher number of patients w...
LSC and RAL HM show similar peri- and postoperative results and a high quality of life, even in long-term (> 24 months) follow-up. Prospective, randomized, controlled multicenter trials are needed to ...
There is a growing prevalence of loneliness and social isolation among older adults (OAs). These problems are often associated with depressive states, cognitive decline, sleep disorders, addictions, a...
The main objective of this study is to measure the impact of a 12-week intervention using a TR on the feeling of loneliness and on social isolation of OAs living at home. Its secondary objective is to...
A nonrandomized study will be conducted among 60 OAs living at home who will participate in the study for 24 weeks. During this period, they will host a TR for 12 weeks to use it in their home. After ...
Data collection started in September 2020 and is expected to be completed in early 2023. In August 2022, 56 participants were recruited for the study. Data analysis will take place between August 2022...
The DOMIROB study will provide new knowledge on the impact of social TRs in OAs living at home. The results will make it possible to suggest technological, ethical, and organizational recommendations ...
ClinicalTrials.gov NCT04767100; https://clinicaltrials.gov/ct2/show/NCT04767100....
DERR1-10.2196/40528....